OppenheimerFunds’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-436,320
Closed -$44.6M 1008
2014
Q4
$44.6M Sell
436,320
-515,157
-54% -$49.4M 0.05% 382
2014
Q3
$82.3M Sell
951,477
-630,350
-40% -$55.8M 0.09% 234
2014
Q2
$143M Sell
1,581,827
-2,631,855
-62% -$197M 0.16% 167
2014
Q1
$310M Sell
4,213,682
-1,314,728
-24% -$91.7M 0.37% 69
2013
Q4
$376M Sell
5,528,410
-7,818,292
-59% -$509M 0.46% 50
2013
Q3
$813M Buy
13,346,702
+5,941,960
+80% +$363M 0.54% 34
2013
Q2
$413M Buy
+7,404,742
New +$428M 0.59% 32

OppenheimerFunds's COV Position: Q1 2015 in Review

OppenheimerFunds sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 436,320 shares — an estimated $44.6M sold.

OppenheimerFunds first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $813M in Q3 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • OppenheimerFunds reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 436,320 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $44.6M.
  • OppenheimerFunds first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • OppenheimerFunds's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $813M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.